Prospects for limiting access to prenatal genetic information about Down syndrome in light of the expansion of prenatal genomics

New Bioeth. 2023 Sep;29(3):226-246. doi: 10.1080/20502877.2022.2130720. Epub 2022 Oct 7.

Abstract

Down syndrome (Trisomy 21) is a mild to moderate intellectual disability. Historically, this condition has been a primary target for prenatal testing. However, Down syndrome has not been targeted for prenatal testing because it is an especially severe illness. The condition was just one that could be easily identified prenatally using the techniques first available decades ago. We are moving into an era in which we can prenatally test for a vast range of human traits. I argue that when we can test for anything, there is no longer any reason to continue targeting Down syndrome. I present an argument based on the value of nondiscrimination. It is justified to set limits on access to prenatal information if the information is going to be used for discriminatory purposes. I use the examples of (1) prenatal testing for misogynistic fetal sex selection, and (2) homophobia-motivated prenatal testing for potential homosexuality, as compelling analogies.

Keywords: Down syndrome; genetic discrimination; genetic testing; nondiscrimination; prenatal testing; sex selection.

MeSH terms

  • Down Syndrome* / diagnosis
  • Down Syndrome* / genetics
  • Female
  • Humans
  • Pregnancy
  • Prenatal Diagnosis / methods
  • Trisomy